Holistic Osteoporosis Care in Maryland
Can 1 or 2 Doses of Zoledronate Prevent Fractures?
Many women in their 50s start thinking about bone health. Osteoporosis medications help high-risk individuals, but what about mild bone loss? A new 10-year study in The New England Journal of Medicine shows that one or two doses of zoledronate significantly reduce fracture risk for a decade. This finding suggests a low-maintenance approach to long-term bone protection.
Published
Bisphosphonate Infusion for Osteopenia
If zoledronate were approved for osteopenia, it could transform fracture prevention strategies for millions of women worldwide. However, questions remain about long-term safety, cost-effectiveness, and patient adherence. Should all women with osteopenia receive treatment, or should therapy be reserved for those at the highest risk?
Published